AKT1 and acute lymphoblastic leukemia: The PI3K-Akt signaling axis has been identified as one of key pathways in T-cell leukemia, with frequent upregulation observed in T-ALL patients and activation of this pathway being associated with poor prognosis, therapeutic resistance, and disease relapse (22, 23, 24, 25).